Endocannabinoid System
Resource Center
/ Recent Posts /
Actual THC or CBD Content is Often Different from What Consumers Expect, says JAMA Study
A buyer-beware study, from Massachusetts General Hospital (MGH), shows that medical cannabis products may be poorly labeled and do not always represent accurate levels of ...
Cannabis Users Need More Anesthesia During Surgery and Opioids in Recovery
Not only might cannabis users need more anesthesia during surgery than non-users, they may have increased pain afterwards and use higher doses of opioids while ...
Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer in Mice
Inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis are caused by unrestrained inflammation of the gastrointestinal tract. Patients with IBD are at ...
Systematic Review and Meta-analysis: Cannabinoids in the Management of Acute Pain
A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing ...
Cannabis for Post-traumatic Stress Disorder Therapy
A new study shows that cannabis may be helpful to address the effects of post-traumatic stress disorder (PTSD). According to health survey data collected by ...
Mayo Clinicians’ Guide to Cannabidiol and Hemp Oil
In this summary-scientific review from Mayo Clinical Proceedings, the researchers provide an overview of the scientific work on cannabidiol and hemp oil and the distinction ...
FDA Announces Early Fall Cannabidiol Hearings and Clarifies Commitment to Enforcement
The FDA announced that it will host further cannabidiol hearing on the regulatory structure of CBD products in the early fall. The news was embedded ...
Medicinal Cannabis Reduces or Ends Seizures in Children with Severe, Drug-resistant Epilepsy
Medicinal cannabis oil containing both cannabidiol (CBD) and a small amount of THC can reduce or end seizures in children with severe, drug-resistant epilepsy, a ...
Could the Endocannabinoid System Offer a New Treatment Target for Obsessive Compulsive Disorder?
The disabling condition of obsessive-compulsive disorder (OCD) affects about 2–3% of people worldwide. Evidence suggests that abnormalities in cortico-striatal-thalamic-cortical circuitry and specific gene variants contribute ...
International Cannabinoid Research Society (ICRS) Names Cannabis and Cannabinoid Research Its Official Journal
New Rochelle, NY, May 7, 2019—Cannabis and Cannabinoid Research (CCR) is extremely excited to announce that the International Cannabinoid Research Society (ICRS) has named CCR ...
